Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diabetes mellitus type 2/albumin

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 217 niðurstöður

Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Introduction Type 2 Diabetes Mellitus is a metabolic syndrome associated with hyperglycemia due to defect in secretion or action of insulin or both. Long term hyperglycemia leads to complications of microvasculature involving the eyes, kidneys and nerves. Diabetic nephropathy (DN) is the commonest

β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The study aims are: - Task 1: pathophysiological characterization of CFRD with assessment of the relative contribution of the insulin resistance and the β-cellular secretion impairment through the use of a Minimum Model applied to OGTT for the evaluation of insulin sensitivity and secretion - Task

Prognostic Factors Keeping Track for COVID-19 Pneumonia

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
It has been reported that nearly half of the patients who are hospitalized for Covid-19 pneumonia have on admission old age or comorbidities. In particular, hypertension was present in 30% of the cases, diabetes in 19%, coronary heart disease in 8% and chronic obstructive lung disease in 3% of the

Niclosamide Role in Diabetic Nephropathy

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The investigators performed a non-randomized single-arm clinical trial with a before and after design, carried out from November 2016 and May 2017. Intervention consisted of the administration of a daily consummation of 425 ml of drink containing the extracts of 1,38mg of leaves extracts of moringa

Multicomponent Integrated Intervention on Metabolic Control and Quality of Life in Type 2 Diabetes: DIABEMPIC Program

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Background: Diabetes mellitus is a chronic metabolic disease with disabling, deadly, and costly consequences for individuals, families, and national health care systems. Proper diabetes management in people living with type 2 diabetes mellitus focuses on reducing the risks for macrovascular and

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
AIMS OF STUDY The aim of this study is to investigate whether ingestion of curcumin will prevent hepatic insulin resistance (assessed by homeostatic model assessment of insulin resistance (HOMA-IR)) induced by short-term oral glucocorticoid (prednisolone) administration in overweight and obese

Effectiveness of SCDM in Patients With Type 2 Diabetes

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. At present, about 114 million diabetics and 11.6% incidence rate of diabetes in China have produced huge chronic disease management pressure and created

Role of Fexofenadine in Diabetic Kidney Disease

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 Diabetes.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The day of the study patients undergo a routine clinical evaluation. Whole blood samples are collected from an antecubital vein to assess serum/plasma aliquots of 200 μl each (frozen at -80°C until required for quantitation) for evaluation of biochemical parameters (fasting glucose, HbA1c, lipid

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Diabetes mellitus type 2 (T2DM) is the most common metabolic disease and its prevalence is rapidly increasing. T2DM is a chronic disease that affects over 451 million people in the world and this number is expected to increase over the years and it is estimated that in 2045 there will be in the

Arterial Composition and Cardiovascular Outcome in DIabeteS

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
PhD project description The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered? Applicant: Anne-Sofie Faarvang Thorsen1, MD Main supervisor: Professor Lars Melholt Rasmussen1 Co-supervisors:

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Diabetic nephropathy (DN) is the most common cause renal failure in Western countries, responsible for 45% of patients on renal replacement therapy.Diabetic nephropathy was characterized in the early stage by increased albumin excretion in urine, known as microalbuminuria. (DN) results from

Piloting Diet and Exercise Interventions in Older Hispanics With Diabetes

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The pilot study will show the potential individual and combined effects of nutrition and exercise programs for disadvantaged older Hispanics with type 2 diabetes. The benefits to the participants include: 1) enhanced type 2 diabetes management; 2) improved diet quality and nutritional status; 3)

Asian Diabetes Outcomes Prevention Trial

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Rationale: Cardiovascular events are the leading cause of death among patients with diabetes. Early identification of high-risk diabetic (DM) patients for intensification of preventive therapy may prevent cardiovascular events. Aims: Among biomarker (N-terminal pro-B-type natriuretic peptide,
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge